Emerald Clinical Trials India Private Limited - Company Profile

It is a pharma foreign private limited company based in Bangalore North, Karnataka, India, established in 2012.
2012 Bangalore North, Karnataka, India Active
Last Updated:
Access Report
About Emerald Clinical Trials India Private Limited

Emerald Clinical Trials India Private Limited, a active foreign private limited company, was established on 04 October 2012 in Bangalore North, Karnataka, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U73100KA2012FTC080639. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Employing 103 professional, Its leadership includes Mamatha Thankam Jacob (Director), Ghosh Dwaipayan (Director), Anthony Stephen Proctor (Director). Past directors included Vinodvenkatesh Ramachandragouda Patil, Ganesh Pai Panduranga, Cheong Kok Hwee. Its latest AGM occurred on 25 September 2024, with the balance sheet filed on 31 March 2024. It is based at Municipal No-5, 12Th Floor Prestige Khoday Towers,, Raj Bhavan Road, Bangalore North, Karnataka, 560001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100KA2012FTC080639

  • Registration Number

    080639

  • Incorporation Date

    04 October 2012

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 13 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** 71.50%
  • Profit Growth **** 114.64%
  • Ebitda **** 96.61%
  • Net Worth 75.37%
  • Total Assets **** 68.81%
Company report

Emerald Clinical Trials India Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Emerald Clinical Trials India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Emerald Clinical Trials India Private Limited?
Current Directors
Name Designation Appointment Date Status
Mamatha Thankam Jacob Director 26 Sep 2024 Current
Ghosh Dwaipayan Director 12 Jun 2025 Current
Anthony Stephen Proctor Director 08 Oct 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 08 Jun 2013 Past
Pramod Abcsdd Director 31 Jul 2021 Past
Pramod Abcsdd Additional Director 27 Aug 2019 Past
Pramod Abcsdd Managing Director 26 Mar 2020 Past
Pramod Abcsdd Additional Director 15 Sep 2020 Past
Pramod Abcsdd Director 01 Aug 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Emerald Clinical Trials India.

George Clinical India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 71.5% increase. The company also saw a substantial improvement in profitability, with a 114.64% increase in profit. The company's net worth Soared by an impressive increase of 75.37%.

Emerald Clinical Trials India revenue growth over time
Emerald Clinical Trials India profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 71.50%
*******
*******
*******
*******
Revenue from Operations
*******
 70.07%
*******
*******
*******
*******
Total Assets
*******
 68.81%
*******
*******
*******
*******
Profit or Loss
*******
 114.64%
*******
*******
*******
*******
Net Worth
*******
 75.37%
*******
*******
*******
*******
EBITDA
*******
 96.61%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Emerald Clinical Trials India?

In 2023, Emerald Clinical Trials India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Emerald Clinical Trials India?

Emerald Clinical Trials India has a workforce of 103 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Emerald Clinical Trials India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emerald Clinical Trials India's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Emerald Clinical Trials India
Recent Activity within the Organization
  • Director Appointment

    The activity Anthony Stephen Proctor was appointed as a Director was appointed as a Director on 08 Oct 2025 & has been associated with this company since 4 months 10 days . was completed.

  • Director Appointment

    Progress on Ghosh Dwaipayan was appointed as a Director was appointed as a Director on 12 Jun 2025 & has been associated with this company since 8 months 5 days . was documented.

  • Director Appointment

    Progress on Mamatha Thankam Jacob was appointed as a Director was appointed as a Director on 26 Sep 2024 & has been associated with this company since 1 year 4 months . was documented.

  • Annual General Meeting

    Progress on Emerald Clinical Trials India Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Emerald Clinical Trials India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.

  • Company Incorporation

    Progress on Emerald Clinical Trials India Private Limited was registered on 04 Oct 2012 with Roc Bangalore & aged 13 years 4 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Emerald Clinical Trials India Private Limited?

The CIN of Emerald Clinical Trials India Private Limited is U73100KA2012FTC080639.

Where is Emerald Clinical Trials India Private Limited headquartered?

Emerald Clinical Trials India Private Limited is headquartered at Municipal No-5, 12Th Floor Prestige Khoday Towers,, Raj Bhavan Road, Bangalore North, Karnataka, 560001.

When was Emerald Clinical Trials India Private Limited incorporated?

Emerald Clinical Trials India Private Limited was incorporated on 04 October 2012.

Who are the current directors of Emerald Clinical Trials India Private Limited?

The current directors of Emerald Clinical Trials India Private Limited are

What is the primary industry of Emerald Clinical Trials India Private Limited?

The primary industry of Emerald Clinical Trials India Private Limited is Professional, Scientific And Technical.

Is Emerald Clinical Trials India Private Limited a listed company?

Emerald Clinical Trials India Private Limited is unlisted.

What is the capital structure of Emerald Clinical Trials India Private Limited?

The authorized capital of Emerald Clinical Trials India Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Emerald Clinical Trials India Private Limited?

The compliance status of Emerald Clinical Trials India Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available